Filtered By:
Nutrition: Weight Loss
This page shows you your search results in order of relevance. This is page number 6.
Order by Relevance | Date
Total 27182 results found since Jan 2013.
Development and validation of a tool for evaluating YouTube-based medical videos
ConclusionCollectively, our findings indicated that the MQ-VET is a valid and reliable tool that will help to standardize future evaluations of online medical videos.
Source: Irish Journal of Medical Science - November 25, 2021 Category: General Medicine Source Type: research
Meridian Medical Weight Loss Center Works With Patients Towards Weight Loss Resolutions
MERIDIAN, Idaho, Feb. 3, 2013 (GLOBE NEWSWIRE) -- Healthy Habits Wellness Center in Meridian, ID is working to help patients successfully achieve their New Year's weight loss resolutions. The Boise medical weight loss center offers the HCG diet for rapid weight loss. According to medical provider Mari Aitken, MSN, NP-c, this diet is a safe and effective way to jump-start long-term weight loss. Daily injections of the naturally occurring hormone HCG supports fat burning while protecting lean muscle mass. Together with nutritional counseling and dietary change, Aitken says that HCG supplements help patients achieve their wei...
Source: Medical News (via PRIMEZONE) - February 4, 2013 Category: Pharmaceuticals Source Type: news
Diet Doc Hormone Diets & Weight Loss Plans Now Offer Medical...
Diet Doc’s prescription hormone medical weight loss plans have successfully helped thousands of their clients burn belly fat by combining exclusive supplements with a healthy, low fat diet.(PRWeb October 09, 2013)Read the full story at http://www.prweb.com/releases/medical-weight-loss/burn-belly-fat/prweb11209767.htm
Source: PRWeb: Medical Pharmaceuticals - October 9, 2013 Category: Pharmaceuticals Source Type: news
Loss of appetite in acutely ill medical inpatients: physiological response or therapeutic target?
Abstract
Loss of appetite and ensuing weight loss is a key feature of severe illnesses. Protein-energy malnutrition (PEM) contributes significantly to the adverse outcome of these conditions. Pharmacological interventions to target appetite stimulation have little efficacy but considerable side effects. Therefore nutritional therapy appears to be the logical step to combat inadequate nutrition. However, clinical trial data demonstrating benefits are sparse and there is no current established standard algorithm for use of nutritional support in malnourished, acutely ill medical inpatients. Recent high-quality evide...
Source: Swiss Medical Weekly - May 4, 2014 Category: Journals (General) Authors: Schütz P, Bally M, Stanga Z, Keller U Tags: Swiss Med Wkly Source Type: research
Rapid Weight Loss in Teenagers Causes Medical Complications Rapid Weight Loss in Teenagers Causes Medical Complications
Adolescents who lost weight rapidly had similar life-threatening complications as those with anorexia nervosa even if they had not yet lost enough weight to be described as underweight. Medscape Medical News
Source: Medscape Medical News Headlines - August 25, 2014 Category: Consumer Health News Tags: Pediatrics News Source Type: news
Sorrento Valley Weight Loss Center Now Offering Customized Medical...
Sorrento Valley Weight Loss Center is now offering medical weight loss with several effective options. The new addition to the treatment options is injections with Lipotropic B12, which helps increase...(PRWeb February 15, 2015)Read the full story at http://www.prweb.com/releases/medical-weight-loss/san-diego-ca/prweb12519529.htm
Source: PRWeb: Medical Pharmaceuticals - February 16, 2015 Category: Pharmaceuticals Source Type: news
How Reshape Medical built an alternative to bariatric surgery for obesity | DeviceTalks Podcast
In this episode of DeviceTalks, we speak with Richard Thompson, CEO of ReShape Medical, about the company’s bariatric surgery alternative for people suffering from obesity.
In July, San Clemente, Calif.-based ReShape won pre-market approval from the FDA for its dual balloon system, indicated to facilitate weight loss in obese adult patients. The system is designed to be inserted endoscopically into the stomach, where it remains for 6 months to help patients feel full. The balloon is meant to be temporary and patients with the device undergo supervised diet and exercise plans to maintain weight loss following its ...
Source: Mass Device - August 31, 2015 Category: Medical Equipment Authors: Brian Johnson Tags: Device Talks Podcasts Diabetes Weight loss ReShape Medical Source Type: news
A new angle for glp-1 receptor agonist: the medical economics argument Editorial on: Huetson P, Palmer JL, Levorsen A, et al. Cost-effectiveness of the once-daily glp-1 receptor agonist lixisenatide compared to bolus insulin both in combination with basal insulin for the treatment of patients with type 2 diabetes in Norway. J Med Econ 2015: 1-13 Epub ahead of print.
Authors: Valencia WM, Florez HJ
Abstract
Glucagon-like peptide-1 receptor agonists (GLP-1 RA) are relatively new medications for diabetes that offer a weight-loss profile that can be considered desirable for patients with both type 2 diabetes (T2D) and obesity. GLP-1 RA are effective in combination with insulin, and even slightly superior or at least equal to short-acting insulin in T2D; however, since they work in the incretin system, they may not be effective in long-standing disease. Additionally, only recently have publications reported their cardiovascular safety, and there is limited evidence for long-term ef...
Source: Journal of Medical Economics - February 13, 2016 Category: Health Management Tags: J Med Econ Source Type: research
EnteroMedics acquires ReShape Medical in $38m cash-and-stock deal
EnteroMedics (NSDQ:ETRM) said today that it acquired ReShape Medical in a cash-and-stock deal worth about $38 million.
The deal called for St. Paul, Minn.-based EnteroMedics to pay $5 million in cash, plus 2.4 million shares of stock and nearly 188,000 series C convertible shares. At yesterday’s closing price of $1.79 per ETRM share, the stock shares would be worth about $4.2 million, with the convertible shares worth another $33.6 million after conversion to nearly 18.8 million shares; EnteroMedics said it plans to hold a shareholder vote by the end of the year to approve the series C conversion.
“We are plea...
Source: Mass Device - October 3, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Mergers & Acquisitions Wall Street Beat Weight loss EnteroMedics Inc. ReShape Medical Source Type: news
Real-world clinical responses in patients with type 2 diabetes mellitus adding exenatide BID (EBID) or mealtime insulin to basal insulin: a retrospective study using electronic medical record data.
CONCLUSIONS: EBID added to basal insulin was as effective in a real-world setting as mealtime insulin added to basal insulin in reducing A1C, with less weight gain and less hypoglycemia for a wide range of A1C attainment levels and baseline values.
PMID: 29394878 [PubMed - as supplied by publisher]
Source: Current Medical Research and Opinion - February 7, 2018 Category: Research Tags: Curr Med Res Opin Source Type: research
Real-World evaluation of Hba1c, blood pressure, and weight loss among patients with type 2 diabetes mellitus treated with canagliflozin: an analysis of electronic medical records from a network of hospitals in Florida.
CONCLUSIONS: In CANA-treated patients and patient subgroups from a network of Florida hospitals, improvements in quality measures and response durability were similar to clinical trials and other real-world studies.
PMID: 29468896 [PubMed - as supplied by publisher]
Source: Current Medical Research and Opinion - February 24, 2018 Category: Research Tags: Curr Med Res Opin Source Type: research
Options Medical Weight Loss ™ Brings Cutting-Edge Weight Loss Solutions to Fishers, Indiana
Options Medical Weight Loss, an industry leader and provider of medical weight loss solutions, is proud to announce the grand opening of its first Indiana location. The opening of Options Medical Weight Loss in Fishers represents an exciting milestone for the company as it expands its...
Source: PRWeb: Medical Pharmaceuticals - September 7, 2023 Category: Pharmaceuticals Tags: CXP Source Type: news
Effectiveness Of Inexpensive Non-Medical Interventions In Improving Obesity And Diabetes Outcomes Addressed By US Endocrinology
With estimates that by 2030 the majority of the world's adults will be overweight or obese and more than 500 million will have type 2 diabetes, the 2013 summer issue of the journal US Endocrinology addresses the potential for inexpensive non-medical interventions to reverse the incidence and prevalence of these inter-related epidemics. A number of the reviews discuss new approaches that replace the focus on widespread food restriction and weight loss with an emphasis on helping people achieve 'energy balance' at a healthy body weight...
Source: Health News from Medical News Today - June 12, 2013 Category: Consumer Health News Tags: Obesity / Weight Loss / Fitness Source Type: news
Obesity Is Now A Disease, American Medical Association Decides
Obesity has been officially recognized as a disease by the American Medical Association, an action that could put more emphasis on the health condition by doctors and insurance companies in order to minimize its effects. The new decision was made at the AMA's annual meeting on Tuesday by delegates in Chicago, and went against a recommendation by a committee that had studied the subject. Dr...
Source: Health News from Medical News Today - June 19, 2013 Category: Consumer Health News Tags: Obesity / Weight Loss / Fitness Source Type: news
Diet Doc Medical Weight Loss Plans Announces Addition of Paleo Diet to...
Diet Doc has added the Paleo diet to their medical diet plan, increasing results and bolstering the nation's best weight loss.(PRWeb September 03, 2013)Read the full story at http://www.prweb.com/releases/paleo-diet/fast-weight-loss/prweb11083135.htm
Source: PRWeb: Medical Pharmaceuticals - September 3, 2013 Category: Pharmaceuticals Source Type: news
